The Buzz of BIO contest provides an excellent opportunity for companies looking to gain exposure and make the connections needed to take their product to the next phase. Winners of the Buzz of BIO contest at the 2018 BIO Investor Forum will receive a complimentary conference registration and company presentation. Presentations are a key programming element, and allow companies to present their pipeline, R&D activities, and future goals to an exclusive audience of private and public equity investors.
Nominations are open today until August 22 at 5 PM ET, or until each category receives ten nominees. Ten biotech’s will be nominated in each of the three categories: Early Stage Entrepreneurs, Late Stage Leaders, and Diagnostics and Beyond. After the nominations period, voting will open and the companies with the most number of votes win.
- To qualify for the Early Stage Entrepreneur Grand Prize, companies must be actively developing a therapeutic product intended for FDA review that addresses human health issues and have raised less than $25 million USD as of July 1, 2018; have been founded after 2015; and have most recently completed either a Seed or Series A financing round. Companies that have previously presented at the BIO Investor Forum are not eligible for the Early Stage Entrepreneur category but are welcome to apply under the Late Stage Leader category (if the company meets the minimum dollar requirements of the Late Stage Leader category).
- To qualify for the Late Stage Leader Grand Prize, companies must be actively developing a therapeutic product intended for FDA review that addresses human health issues and have raised more than $25 million USD as of July 1, 2018 and have enrolled at least one patient in a company-sponsored clinical trial posted at https://clinicaltrials.gov.
- To qualify for the Diagnostics and Beyond category, companies must be primarily focused in medical diagnostics, drug delivery, drug development tools, or digital health technologies.
To nominate your company for Buzz of BIO, click here.
The BIO Investor Forum is an international biotech investor conference focused on investment opportunities in life sciences, with emphasis on venture-stage growth and emerging public companies as well as those poised to join the growth “watch-list” in 2019. The event features plenary sessions, business roundtables and therapeutic workshops, more than 160 public and venture-stage company presentations, premiere industry-focused networking opportunities, and over 2,700 BIO One-on-One Partnering™ meetings.
Don’t miss this exciting opportunity to be recognized. Good luck!
Early bird registration rates are available through September 9. Media registration is also available for qualified members of the press.
*Due to the complexities of international laws regarding contests, only U.S. residents who are 21 years of age or older are eligible to enter.
0 Comments
Comments are closed.